SGK1 in Cancer: Biomarker and Drug Target
Serum- and glucocorticoid-regulated kinases (SGKs) are members of the AGC family of serine/threonine kinases, consisting of three isoforms: SGK1, SGK2, and SGK3. SGK1 was initially cloned as a gene transcriptionally stimulated by serum and glucocorticoids in rat mammary tumor cells. It is upregulate...
Main Authors: | Jonas Cicenas, Edita Meskinyte-Kausiliene, Vigilijus Jukna, Arnas Rimkus, Jokubas Simkus, Diana Soderholm |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/10/2385 |
Similar Items
-
JNK, p38, ERK, and SGK1 Inhibitors in Cancer
by: Jonas Cicenas, et al.
Published: (2017-12-01) -
SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition
by: Cristina Talarico, et al.
Published: (2016-10-01) -
Identification of a new structural family of SGK1 inhibitors as potential neuroprotective agents
by: Ines Maestro, et al.
Published: (2023-12-01) -
SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation
by: Lucia D''Antona, et al.
Published: (2015-03-01) -
Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy
by: Ilaria Guerriero, et al.
Published: (2020-11-01)